Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

sciencedaily.com / .sciencedaily-com-most-popular / Page 3

Latest Science News -- ScienceDaily
Quick Menu features require JavaScript!
Popular News
 
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance ...
A prebiotic fiber supplement reduced knee osteoarthritis pain while also improving grip strength and pain sensitivity in a six-week trial. The results hint at a fascinating gut-muscle-pain connection and suggest that a simple daily supplement may be ...
Scientists have uncovered new evidence that Venus may still be tearing itself apart from within. Advanced 3D simulations indicate that some of the planet's giant rift valleys formed relatively recently and could still be expanding. The results ...
A new analysis suggests the Sun holds far more silver than earlier estimates indicated. More advanced models of the solar atmosphere raised the calculated amount by 55 percent, bringing it into much closer agreement with ancient meteorites. The ...
Stanford Medicine researchers have discovered a naturally occurring molecule that may suppress appetite and reduce body weight much like Ozempic, but without several of its common side effects. The molecule, called BRP, acts on a more targeted region ...
Ozempic, Wegovy, and similar drugs may deliver excellent health value, but covering them for millions of eligible patients could overwhelm insurance budgets. Researchers say better long-term support is needed and warn that low-cost compounded ...
Sweden could become an important source of rare earth elements needed for magnets and green technologies. Instead of extracting one target metal, researchers are cataloging everything contained in Swedish mineral deposits. They will then develop ...
Continue
Please wait ...